Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

Illumina - Liquid biopsy-based biomarkers for cancer profiling and monitoring: current and future applications

National implementation of Liquid Biopsy testing for Non Small Cell Lung Cancer – QuicDNA

Date

15 Sep 2024

Session

Illumina - Liquid biopsy-based biomarkers for cancer profiling and monitoring: current and future applications

Topics

Cancer Diagnostics;  Cancer Research

Tumour Site

Presenters

Magdalena Meissner

Authors

M. Meissner

Author affiliations

  • Early Phase Clinical Cancer Trials Dept., Velindre Cancer Centre - Velindre NHS University Trust - NHS Wales, CF14 2TL - Cardiff/GB

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Welcome

Presenter: Umberto Malapelle

Session: Illumina - Liquid biopsy-based biomarkers for cancer profiling and monitoring: current and future applications

Resources:

Webcast

Panel discuss

Presenter: Umberto Malapelle, Magdalena Meissner, Åslaug Helland, Stephen Rowley

Session: Illumina - Liquid biopsy-based biomarkers for cancer profiling and monitoring: current and future applications

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.